LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 45

Search options

  1. Article ; Online: Extracellular adenosine: a critical signal in liver fibrosis.

    Fausther, Michel

    American journal of physiology. Gastrointestinal and liver physiology

    2018  Volume 315, Issue 1, Page(s) G12–G19

    Abstract: Extracellular adenosine nucleoside is a potent, endogenous mediator that signals through specific G protein-coupled receptors, and exerts pleiotropic effects on liver physiology, in health and disease. Particularly, adenosinergic or adenosine-mediated ... ...

    Abstract Extracellular adenosine nucleoside is a potent, endogenous mediator that signals through specific G protein-coupled receptors, and exerts pleiotropic effects on liver physiology, in health and disease. Particularly, adenosinergic or adenosine-mediated signaling pathways impact the progression of hepatic fibrosis, a common feature of chronic liver diseases, through regulation of matrix deposition by liver myofibroblasts. This review examines the current lines of evidence on adenosinergic regulation of liver fibrosis and myofibroblasts, identifies unanswered research questions, and proposes important future areas of investigation.
    MeSH term(s) Adenosine/metabolism ; Disease Progression ; Humans ; Liver Cirrhosis/metabolism ; Liver Cirrhosis/pathology ; Myofibroblasts/metabolism ; Signal Transduction
    Chemical Substances Adenosine (K72T3FS567)
    Language English
    Publishing date 2018-03-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 603840-2
    ISSN 1522-1547 ; 0193-1857
    ISSN (online) 1522-1547
    ISSN 0193-1857
    DOI 10.1152/ajpgi.00006.2018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Beyond scar formation: portal myofibroblast-mediated angiogenesis in the fibrotic liver.

    Fausther, Michel / Dranoff, Jonathan A

    Hepatology (Baltimore, Md.)

    2015  Volume 61, Issue 3, Page(s) 766–768

    MeSH term(s) Animals ; Cell-Derived Microparticles/secretion ; Humans ; Liver/cytology ; Liver Cirrhosis/etiology ; Male ; Myofibroblasts/physiology ; Vascular Remodeling
    Language English
    Publishing date 2015-03
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.27653
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Integrins, myofibroblasts, and organ fibrosis.

    Fausther, Michel / Dranoff, Jonathan A

    Hepatology (Baltimore, Md.)

    2014  Volume 60, Issue 2, Page(s) 756–758

    MeSH term(s) Animals ; Female ; Integrin alphaV/metabolism ; Kidney/pathology ; Kidney Diseases/genetics ; Liver Cirrhosis/genetics ; Male ; Pulmonary Fibrosis/genetics
    Chemical Substances Integrin alphaV
    Language English
    Publishing date 2014-05-09
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.27155
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants.

    Fausther, Michel / G Lavoie, Elise / Dranoff, Jonathan A

    PloS one

    2017  Volume 12, Issue 9, Page(s) e0184499

    Abstract: Liver myofibroblasts are specialized effector cells that drive hepatic fibrosis, a hallmark process of chronic liver diseases, leading to progressive scar formation and organ failure. Liver myofibroblasts are increasingly recognized as heterogeneous with ...

    Abstract Liver myofibroblasts are specialized effector cells that drive hepatic fibrosis, a hallmark process of chronic liver diseases, leading to progressive scar formation and organ failure. Liver myofibroblasts are increasingly recognized as heterogeneous with regards to their origin, phenotype, and functions. For instance, liver myofibroblasts express cell markers that are universally represented such as, ItgαV and Pdgfrβ, or restricted to a given subpopulation such as, Lrat exclusively expressed in hepatic stellate cells, and Gpm6a in mesothelial cells. To study liver myofibroblasts in vitro, we have previously generated and characterized a SV40-immortalized polyclonal rat activated portal fibroblast cell line called RGF-N2 expressing multiple mesothelin mRNA transcripts. Mesothelin, a cell-surface molecule expressed in normal mesothelial cells and overexpressed in several cancers such as, mesothelioma and cholangiocarcinoma, was recently identified as a key regulator of portal myofibroblast proliferation, and fibrosis progression in the setting of chronic cholestatic liver disease. Here, we identify novel mesothelin splice variants expressed in rat activated portal fibroblasts. RGF-N2 portal fibroblast cDNA was used as template for insertion of hemagglutinin tag consensus sequence into the complete open reading frame of rat mesothelin variant coding sequences by extension PCR. Purified amplicons were subsequently cloned into an expression vector for in vitro translation and transfection in monkey COS7 fibroblasts, before characterization of fusion proteins by immunoblot and immunofluorescence. We show that rat activated portal fibroblasts, hepatic stellate cells, and cholangiocarcinoma cells express wild-type mesothelin and additional splice variants, while mouse activated hepatic stellate cells appear to only express wild-type mesothelin. Notably, rat mesothelin splice variants differ from the wild-type isoform by their protein properties and cellular distribution in transfected COS7 fibroblasts. We conclude that mesothelin is a marker of activated murine liver myofibroblasts. Mesothelin gene expression and regulation may be critical in liver myofibroblasts functions and fibrosis progression.
    MeSH term(s) Animals ; COS Cells ; Cell Line, Tumor ; Cells, Cultured ; Chlorocebus aethiops ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/metabolism ; Hepatic Stellate Cells/metabolism ; Liver/cytology ; Liver/metabolism ; Male ; Mice ; Myofibroblasts/metabolism ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; RNA Splicing ; Rats ; Rats, Sprague-Dawley
    Chemical Substances GPI-Linked Proteins ; Protein Isoforms ; mesothelin (J27WDC343N)
    Language English
    Publishing date 2017-09-12
    Publishing country United States
    Document type Journal Article
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0184499
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Contribution of Liver Nonparenchymal Cells to Hepatic Fibrosis: Interactions with the Local Microenvironment.

    Fausther, Michel / Pritchard, Michele T / Popov, Yury V / Bridle, Kim

    BioMed research international

    2017  Volume 2017, Page(s) 6824762

    MeSH term(s) Animals ; Cellular Microenvironment ; Humans ; Liver/metabolism ; Liver/pathology ; Liver Cirrhosis/metabolism ; Liver Cirrhosis/pathology
    Language English
    Publishing date 2017-02-16
    Publishing country United States
    Document type Editorial
    ZDB-ID 2698540-8
    ISSN 2314-6141 ; 2314-6133
    ISSN (online) 2314-6141
    ISSN 2314-6133
    DOI 10.1155/2017/6824762
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: The cholangiocyte adenosine-IL6 axis regulates survival during biliary cirrhosis.

    Lavoie, Elise / Fausther, Michel / Goree, Jessica / Dranoff, Jonathan A

    Gene expression

    2017  

    Abstract: BACKGROUND AND AIMSEpithelial response to injury is critical to the pathogenesis of biliary cirrhosis, and IL6 has been suggested as a mediator of this phenomenon. Several liver cell types can secrete IL6 following activation by various signaling ... ...

    Abstract BACKGROUND AND AIMSEpithelial response to injury is critical to the pathogenesis of biliary cirrhosis, and IL6 has been suggested as a mediator of this phenomenon. Several liver cell types can secrete IL6 following activation by various signaling molecules including circulating adenosine. The aims of this study are to assess whether adenosine can induce IL6 secretion by cholangiocytes via the A2b adenosine receptor (A2bAR) and determine the effect of A2bAR-sensitive IL6 release on injury response in biliary cirrhosis.METHODSHuman normal cholangiocyte H69 cells were used for in vitro studies to determine the mechanism by which adenosine and the A2bAR induces release of IL6. In vivo, control and A2bAR-deficient mice were used to determine the roles of A2bAR-sensitive IL6 release in biliary cirrhosis induced by common bile duct ligation (BDL). Additionally, the response to exogenous IL6 was assessed in C57BL/6 and A2bAR-deficient mice.RESULTSAdenosine induced IL6 mRNA expression and protein secretion via A2bAR activation. Although activation of A2bAR induced cAMP and intracellular Ca
    Language English
    Publishing date 2017--11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1151108-4
    ISSN 1052-2166 ; 1052-2116
    ISSN 1052-2166 ; 1052-2116
    DOI 10.3727/105221617X15042723767876
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts.

    Fausther, Michel / Lavoie, Elise G / Goree, Jessica R / Dranoff, Jonathan A

    Purinergic signalling

    2017  Volume 13, Issue 4, Page(s) 417–428

    Abstract: Hepatic fibrosis represents a pathological wound healing and tissue repair process triggered in response to chronic liver injury. A heterogeneous population of activated non-parenchymal liver cells, known as liver myofibroblasts, functions as the ... ...

    Abstract Hepatic fibrosis represents a pathological wound healing and tissue repair process triggered in response to chronic liver injury. A heterogeneous population of activated non-parenchymal liver cells, known as liver myofibroblasts, functions as the effector cells in hepatic fibrosis. Upon activation, liver myofibroblasts become fibrogenic, acquiring contractile properties and increasing collagen production capacity, while developing enhanced sensitivity to endogenous molecules and factors released in the local microenvironment. Hepatic extracellular adenosine is a bioactive small molecule, increasingly recognized as an important regulator of liver myofibroblast functions, and an important mediator in the pathogenesis of liver fibrosis overall. Remarkably, ecto-5'-nucleotidase/Nt5e/Cd73 enzyme, which accounts for the dominant adenosine-generating activity in the extracellular medium, is expressed by activated liver myofibroblasts. However, the molecular signals regulating Nt5e gene expression in liver myofibroblasts remain poorly understood. Here, we show that activated mouse liver myofibroblasts express Nt5e gene products and characterize the putative Nt5e minimal promoter in the mouse species. We describe the existence of an enhancer sequence upstream of the mouse Nt5e minimal promoter and establish that the mouse Nt5e minimal promoter transcriptional activity is negatively regulated by an Elf2-like Ets-related transcription factor in activated mouse liver myofibroblasts.
    MeSH term(s) 5'-Nucleotidase/biosynthesis ; Animals ; DNA-Binding Proteins/metabolism ; Gene Expression Regulation/physiology ; Liver Cirrhosis/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Myofibroblasts/metabolism ; Transcription Factors/metabolism
    Chemical Substances DNA-Binding Proteins ; Elf2 protein, mouse ; Transcription Factors ; 5'-Nucleotidase (EC 3.1.3.5)
    Language English
    Publishing date 2017-06-30
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2172143-9
    ISSN 1573-9546 ; 1573-9538
    ISSN (online) 1573-9546
    ISSN 1573-9538
    DOI 10.1007/s11302-017-9570-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Extracellular nucleosides and nucleotides regulate liver functions via a complex system of membrane proteins.

    Fausther, Michel / Sévigny, Jean

    Comptes rendus biologies

    2011  Volume 334, Issue 2, Page(s) 100–117

    Abstract: Nucleosides and nucleotides are now considered as extracellular signalling molecules, like neurotransmitters and hormones. Hepatic cells, amongst other cells, ubiquitously express specific transmembrane receptors that transduce the physiological signals ... ...

    Abstract Nucleosides and nucleotides are now considered as extracellular signalling molecules, like neurotransmitters and hormones. Hepatic cells, amongst other cells, ubiquitously express specific transmembrane receptors that transduce the physiological signals induced by extracellular nucleosides and nucleotides, as well as various cell surface enzymes that regulate the levels of these mediators in the extracellular medium. Here, we cover various aspects of the signalling pathways initiated by extracellular nucleosides and nucleotides in the liver, and discuss their overall impact on hepatic physiology.
    MeSH term(s) Adenosine Triphosphate/physiology ; Animals ; Extracellular Fluid/physiology ; Hepatocytes/metabolism ; Humans ; Liver/metabolism ; Liver/physiology ; Membrane Proteins/physiology ; Mice ; Nucleosides/physiology ; Nucleotides/physiology ; Phosphoric Diester Hydrolases/metabolism ; Phosphoric Monoester Hydrolases/metabolism ; Pyrophosphatases/metabolism ; Receptors, Purinergic/physiology ; Signal Transduction/physiology
    Chemical Substances Membrane Proteins ; Nucleosides ; Nucleotides ; Receptors, Purinergic ; Adenosine Triphosphate (8L70Q75FXE) ; Phosphoric Monoester Hydrolases (EC 3.1.3.2) ; Phosphoric Diester Hydrolases (EC 3.1.4.-) ; Pyrophosphatases (EC 3.6.1.-)
    Language French
    Publishing date 2011-02
    Publishing country France
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2072863-3
    ISSN 1768-3238 ; 1631-0691
    ISSN (online) 1768-3238
    ISSN 1631-0691
    DOI 10.1016/j.crvi.2010.12.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice.

    Fausther, Michel / Dranoff, Jonathan A

    Journal of hepatology

    2011  Volume 55, Issue 4, Page(s) 939–940

    Abstract: The nuclear bile acid receptor, farnesoid X receptor (FXR), may play a pivotal role in liver fibrosis. We tested the impact of genetic FXR ablation in four different mouse models. Hepatic fibrosis was induced in wild-type and FXR knock-out mice (FXR((-/-) ...

    Abstract The nuclear bile acid receptor, farnesoid X receptor (FXR), may play a pivotal role in liver fibrosis. We tested the impact of genetic FXR ablation in four different mouse models. Hepatic fibrosis was induced in wild-type and FXR knock-out mice (FXR((-/-))) by CCl(4) intoxication, 3,5-diethoxycarbonyl-1,4-dihydrocollidine feeding, common bile duct ligation, or Schistosoma mansoni (S.m.)-infection. In addition, we determined nuclear receptor expression levels (FXR, pregnane X receptor (PXR), vitamin D receptor, constitutive androstane receptor (CAR), small heterodimer partner (SHP)) in mouse hepatic stellate cells (HSCs), portal myofibroblasts (MFBs), and human HSCs. Cell type-specific FXR protein expression was determined by immunohistochemistry in five mouse models and prototypic human fibrotic liver diseases. Expression of nuclear receptors was much lower in mouse and human HSCs/MFBs compared with total liver expression with the exception of vitamin D receptor. FXR protein was undetectable in mouse and human HSCs and MFBs. FXR loss had no effect in CCl(4)-intoxicated and S.m.-infected mice, but significantly decreased liver fibrosis of the biliary type (common bile duct ligation, 3,5-diethoxycarbonyl-1,4-dihydrocollidine). These data suggest that FXR loss significantly reduces fibrosis of the biliary type, but has no impact on non-cholestatic liver fibrosis. Since there is no FXR expression in HSCs and MFBs in liver fibrosis, our data indicate that these cells may not represent direct therapeutic targets for FXR ligands.
    Language English
    Publishing date 2011-05-11
    Publishing country Netherlands
    Document type Comment ; Journal Article
    ZDB-ID 605953-3
    ISSN 1600-0641 ; 0168-8278
    ISSN (online) 1600-0641
    ISSN 0168-8278
    DOI 10.1016/j.jhep.2011.04.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Ticlopidine in its prodrug form is a selective inhibitor of human NTPDase1.

    Lecka, Joanna / Fausther, Michel / Künzli, Beat / Sévigny, Jean

    Mediators of inflammation

    2014  Volume 2014, Page(s) 547480

    Abstract: Nucleoside triphosphate diphosphohydrolase-1 (NTPDase1), like other ectonucleotidases, controls extracellular nucleotide levels and consequently their (patho)physiological responses such as in thrombosis, inflammation, and cancer. Selective NTPDase1 ... ...

    Abstract Nucleoside triphosphate diphosphohydrolase-1 (NTPDase1), like other ectonucleotidases, controls extracellular nucleotide levels and consequently their (patho)physiological responses such as in thrombosis, inflammation, and cancer. Selective NTPDase1 inhibitors would therefore be very useful. We previously observed that ticlopidine in its prodrug form, which does not affect P2 receptor activity, inhibited the recombinant form of human NTPDase1 (K i = 14 μM). Here we tested whether ticlopidine can be used as a selective inhibitor of NTPDase1. We confirmed that ticlopidine inhibits NTPDase1 in different forms and in different assays. The ADPase activity of intact HUVEC as well as of COS-7 cells transfected with human NTPDase1 was strongly inhibited by 100 µM ticlopidine, 99 and 86%, respectively. Ticlopidine (100 µM) completely inhibited the ATPase activity of NTPDase1 in situ as shown by enzyme histochemistry with human liver and pancreas sections. Ticlopidine also inhibited the activity of rat and mouse NTPDase1 and of potato apyrase. At 100 µM ticlopidine did not affect the activity of human NTPDase2, NTPDase3, and NTPDase8, nor of NPP1 and NPP3. Weak inhibition (10-20%) of NTPDase3 and -8 was observed at 1 mM ticlopidine. These results show that ticlopidine is a specific inhibitor of NTPDase1 that can be used in enzymatic and histochemistry assays.
    MeSH term(s) Adenosine Triphosphatases/metabolism ; Animals ; Antigens, CD/metabolism ; Apyrase/metabolism ; COS Cells ; Chlorocebus aethiops ; Enzyme Activation/drug effects ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/pharmacology ; Human Umbilical Vein Endothelial Cells ; Humans ; Pyrophosphatases/metabolism ; Ticlopidine/chemistry ; Ticlopidine/pharmacology
    Chemical Substances Antigens, CD ; Enzyme Inhibitors ; Adenosine Triphosphatases (EC 3.6.1.-) ; Pyrophosphatases (EC 3.6.1.-) ; ectoATPase (EC 3.6.1.-) ; nucleoside-triphosphate diphosphohydrolase 3 (EC 3.6.1.-) ; Apyrase (EC 3.6.1.5) ; CD39 antigen (EC 3.6.1.5) ; Ticlopidine (OM90ZUW7M1)
    Language English
    Publishing date 2014-08-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1137605-3
    ISSN 1466-1861 ; 0962-9351
    ISSN (online) 1466-1861
    ISSN 0962-9351
    DOI 10.1155/2014/547480
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top